Request more information or explore ordering options to bring Foresight to your practice.
Request more information about how Myriad’s prenatal screening options can benefit your patients.
Carrier screening identifies couples who are at risk of passing serious inherited conditions to their children. Foresight elevates quality of care by offering carrier screening for all patients, regardless of ancestry or ability to pay.
Through proven, superior technology, Foresight is designed to maximize the detection of couples at risk of passing down a serious, inheritable condition to their baby.
Screen for diseases that matter most
Bigger is not always better. Foresight’s carefully selected universal panel of 176 genes prioritizes clinical significance. These genes were selected based on associated condition severity, condition prevalence, clinical actionability of results, and detection sensitivity.
Detect at-risk couples with unmatched technology
Foresight offers the highest published at-risk couple detection rate for serious inherited conditions (1 in 22 couples)1 in our Universal panel. You can trust both positive and negative screening results – the detection rate for the vast majority of genes on our panel is over 99% across ethnicities.2
Test with a proven, trusted partner
Foresight is the only validated carrier screening panel in the US, backed by 20+ peer-reviewed publications and >900,000 patients screened.
Foresight offers three panel choices that allow you to test for up to 176 genes associated with serious and prevalent inherited conditions.
Screens for cystic fibrosis and spinal muscular atrophy (recommended by ACMG and ACOG).3,4
Screens for a guideline-based set of 14 genes.
Screens for 176 genes associated with serious and prevalent inherited conditions.
Panels may be customized based on clinical needs.
Every Foresight Carrier Screen delivers a detailed report that includes test results, testing methodology, carrier results for each condition, and recommended next steps for patient care based on medical society guidelines.
For patients receiving a positive carrier result for one of the screened conditions, the Foresight report provides a comprehensive overview of the condition(s), the patient’s specific variant(s), and details about the screening methodology and interpretation. Positive carrier results also provide recommended next steps, which may include partner testing and/or genetic counseling.
Test results are typically available within two weeks of sample submission (blood or saliva).
Foresight’s results help clinicians guide care and empower patients to take action to make the best decision for their families.
Pursuing diagnostic testing
Consulting with specialists
Planning for pregnancy and delivery
Understanding alternative family-building options
After screening with Foresight, Ashley and her husband discovered that they are both carriers of spinal muscular atrophy, also known as SMA. Knowing the Pantiers’ carrier status allowed physicians to diagnose their children faster and intervene quickly with time-sensitive treatment.
“If it weren’t for the results of our carrier screening, we wouldn’t have had such a great plan of action to help our children.”
From on-demand patient education to clear results reporting, Myriad offers seamless patient care throughout the entire Foresight screening process.
Foresight patients have unlimited access to one of Myriad’s 50+ board-certified genetic counselors to help understand the steps of carrier and prenatal screenings and their results.
Discuss Foresight screening with your patient and collect a patient sample (blood or saliva)
Submit patient sample and completed Test Request Form to Myriad
Receive results in less than two weeks and review with patient
Refer patients to schedule a consultation with Myriad’s board-certified genetic counselors
Every Foresight Carrier Screen provides actionable results within two weeks to inform patient care decisions.
Myriad is committed to providing patients with access to reliable and affordable genetic results through extensive coverage with most insurance plans and financial assistance programs.
Myriad believes in providing the highest quality tests for patients. From prenatal screens to precision medicine, our tests are designed to give healthcare providers and patients the most reliable answer possible.
MyRisk® Hereditary Cancer Test is a multi-gene panel that helps to determine a patient’s risk by evaluating a number of hereditary cancer syndromes, with focus on 11 primary cancer sites.
Designed for everyone regardless of ancestry and BMI or ability to pay, the Prequel® Prenatal Screen can determine if a pregnancy is at an increased risk for a wide variety of chromosomal conditions as early as 10 weeks.